{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:27:31Z","timestamp":1720657651607},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Dermatology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.yadr.2007.08.001","type":"journal-article","created":{"date-parts":[[2007,11,21]],"date-time":"2007-11-21T10:33:32Z","timestamp":1195641212000},"page":"197-229","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Genetic Immunodeficiency Diseases"],"prefix":"10.1016","volume":"23","author":[{"given":"Melissa","family":"Abrams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Paller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yadr.2007.08.001_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib2","first-page":"156","article-title":"When earaches and sore throats are more than a pain in the neck","volume":"17","author":"Skoda-Smith","year":"2000","journal-title":"Contemp Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006454-200102000-00017","article-title":"Chronic mucocutaneous candidiasis","volume":"20","author":"Kirkpatrick","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.yadr.2007.08.001_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ni906","article-title":"Aire regulates negative selection of organ-specific T cells","volume":"4","author":"Liston","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib5","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1128\/IAI.71.10.5690-5699.2003","article-title":"Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis","volume":"71","author":"Lilic","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.yadr.2007.08.001_bib6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","article-title":"Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yadr.2007.08.001_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00109-001-0306-2","article-title":"The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components","volume":"80","author":"Vogel","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/j.yadr.2007.08.001_bib8","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1210\/jc.87.6.2568","article-title":"AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype","volume":"87","author":"Halonen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yadr.2007.08.001_bib9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1365-2133.2006.07166.x","article-title":"Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome","volume":"154","author":"Collins","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.yadr.2007.08.001_bib10","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1001\/archderm.1988.01670090067015","article-title":"Abnormal elastic tissue in cartilage-hair hypoplasia","volume":"124","author":"Brennan","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.yadr.2007.08.001_bib11","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1093\/hmg\/ddi403","article-title":"Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia","volume":"14","author":"Hermanns","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yadr.2007.08.001_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1067\/mpd.2000.108102","article-title":"Deficiency of humoral immunity in cartilage-hair hypoplasia","volume":"137","author":"Makitie","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(99)70456-7","article-title":"Increased incidence of cancer in patients with cartilage-hair hypoplasia","volume":"134","author":"Makitie","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0105-2896.2005.00233.x","article-title":"Genetic analysis of patients with defects in early B-cell development","volume":"203","author":"Conley","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.yadr.2007.08.001_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0190-9622(95)90016-0","article-title":"Genetic immunodeficiencies: cutaneous manifestations and recent progress","volume":"33","author":"Arbiser","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.yadr.2007.08.001_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","article-title":"X-linked agammaglobulinemia: an analysis of 96 patients","volume":"64","author":"Lederman","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yadr.2007.08.001_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00005792-199611000-00001","article-title":"X-linked agammaglobulinemia. A clinical and molecular analysis","volume":"75","author":"Ochs","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yadr.2007.08.001_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaci.2006.01.038","article-title":"Molecular basis of common variable immunodeficiency","volume":"117","author":"Castigli","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.yadr.2007.08.001_bib20","first-page":"1","article-title":"Report of a WHO scientific group","volume":"109","author":"Primary immunodeficiency diseases","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00915550","article-title":"Incidence of cancer in 98\u00a0patients with common varied immunodeficiency","volume":"7","author":"Cunningham-Rundles","year":"1987","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.yadr.2007.08.001_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF00917124","article-title":"Clinical and immunologic analyses of 103 patients with common variable immunodeficiency","volume":"9","author":"Cunningham-Rundles","year":"1989","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF00917151","article-title":"Anti-IgA antibodies in IgA-deficient children","volume":"8","author":"Sennhauser","year":"1988","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yadr.2007.08.001_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/clim.2000.4956","article-title":"Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome","volume":"97","author":"Minegishi","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","article-title":"Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)","volume":"102","author":"Revy","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.yadr.2007.08.001_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(98)70239-7","article-title":"Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome","volume":"38","author":"Chang","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.yadr.2007.08.001_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00273996","article-title":"Mapping the mutation causing the X-linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq","volume":"82","author":"Skare","year":"1989","journal-title":"Hum Genet"},{"key":"10.1016\/j.yadr.2007.08.001_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-3476(80)80133-8","article-title":"The Wiskott-Aldrich syndrome in the United States and Canada (1892\u20131979)","volume":"97","author":"Perry","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib31","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s00018-004-4086-z","article-title":"The Wiskott-Aldrich syndrome","volume":"61","author":"Orange","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.yadr.2007.08.001_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.all.0000191243.25757.ce","article-title":"WASP and the phenotypic range associated with deficiency","volume":"5","author":"Notarangelo","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2249.2004.02409.x","article-title":"Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation","volume":"136","author":"Park","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00002281-200307000-00012","article-title":"Autoimmunity in Wiskott-Aldrich syndrome","volume":"15","author":"Schurman","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.yadr.2007.08.001_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","article-title":"The Wiskott-Aldrich syndrome","volume":"117","author":"Ochs","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","article-title":"A multiinstitutional survey of the Wiskott-Aldrich syndrome","volume":"125","author":"Sullivan","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clim.2003.08.005","article-title":"An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome","volume":"109","author":"Conley","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3476(96)70248-2","article-title":"Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center","volume":"129","author":"Ozsahin","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib39","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1056\/NEJMp068062","article-title":"Disabled receptor signaling and new primary immunodeficiency disorders","volume":"354","author":"Rudd","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yadr.2007.08.001_bib40","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200423571","article-title":"The multiple causes of human SCID","volume":"114","author":"Buckley","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yadr.2007.08.001_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/73208","article-title":"Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease","volume":"6","author":"Kung","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.yadr.2007.08.001_bib42","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S1097-2765(01)00408-7","article-title":"DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency","volume":"8","author":"O'Driscoll","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.yadr.2007.08.001_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI10993","article-title":"Familial CD8 deficiency due to a mutation in the CD8 alpha gene","volume":"108","author":"de la Calle-Martin","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yadr.2007.08.001_bib44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jaci.2006.01.041","article-title":"Gene therapy for immune disorders: good news tempered by bad news","volume":"117","author":"Puck","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199902183400703","article-title":"Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"340","author":"Buckley","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yadr.2007.08.001_bib46","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2004.01.762","article-title":"The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation","volume":"113","author":"Orange","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib47","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI18714","article-title":"A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency","volume":"112","author":"Courtois","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yadr.2007.08.001_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0092-8674(88)90382-0","article-title":"Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor","volume":"53","author":"Baeuerle","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.yadr.2007.08.001_bib49","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1172\/JCI19960","article-title":"Finding NEMO: genetic disorders of NF-[kappa]B activation","volume":"112","author":"Orange","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yadr.2007.08.001_bib50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.all.0000191241.66373.74","article-title":"The range of defects associated with nuclear factor kappaB essential modulator","volume":"5","author":"Uzel","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","article-title":"X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling","volume":"27","author":"Doffinger","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.yadr.2007.08.001_bib52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaci.2004.06.052","article-title":"Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia","volume":"114","author":"Orange","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0105-2896.2005.00221.x","article-title":"Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation","volume":"203","author":"Orange","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.yadr.2007.08.001_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coi.2003.11.013","article-title":"Inherited disorders of NF-kappaB-mediated immunity in man","volume":"16","author":"Puel","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.yadr.2007.08.001_bib56","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/jnci\/92.10.795","article-title":"Cancer risk and the ATM gene: a continuing debate","volume":"92","author":"Khanna","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.yadr.2007.08.001_bib57","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/carcin\/23.10.1617","article-title":"Deficiency in the repair of UV-induced DNA damage in human skin fibroblasts compromised for the ATM gene","volume":"23","author":"Hannan","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yadr.2007.08.001_bib58","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-3476(05)83043-4","article-title":"Cutaneous granulomatous lesions in patients with ataxia-telangiectasia","volume":"119","author":"Paller","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","article-title":"Immunodeficiency and infections in ataxia-telangiectasia","volume":"144","author":"Nowak-Wegrzyn","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00043426-200009000-00017","article-title":"Lymphoid malignancy as a presenting sign of ataxia-telangiectasia","volume":"22","author":"Loeb","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.yadr.2007.08.001_bib61","first-page":"89","article-title":"Mortality and cancer incidence in 263 patients with ataxia-telangiectasia","volume":"77","author":"Morrell","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.yadr.2007.08.001_bib62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2249.2005.02782.x","article-title":"Growth factor deficiency in patients with ataxia telangiectasia","volume":"140","author":"Schubert","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmet.2006.10.009","article-title":"Banking on ATM as a new target in metabolic syndrome","volume":"4","author":"Shoelson","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.yadr.2007.08.001_bib64","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5","article-title":"Ovarian differentiation and gonadal failure","volume":"89","author":"Simpson","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.yadr.2007.08.001_bib65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00228.x","article-title":"Hyper-IgE syndromes","volume":"203","author":"Grimbacher","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.yadr.2007.08.001_bib66","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1086\/302547","article-title":"Genetic linkage of hyper-IgE syndrome to chromosome 4","volume":"65","author":"Grimbacher","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yadr.2007.08.001_bib67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-6749(99)70510-5","article-title":"Regulation of immunoglobulin production in hyper-IgE (Job's) syndrome","volume":"103","author":"Garraud","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0022-3476(00)70098-9","article-title":"Defective interleukin-12\/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome","volume":"136","author":"Borges","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib69","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1067\/mpd.2002.127503","article-title":"Cutaneous manifestations of hyper-IgE syndrome in infants and children","volume":"141","author":"Chamlin","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib70","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-4362.2001.01271.x","article-title":"The hyper-IgE syndrome. Two cases and review of the literature","volume":"40","author":"Shemer","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.yadr.2007.08.001_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","article-title":"Autosomal recessive hyperimmunoglobulin E\u00a0syndrome: a distinct disease entity","volume":"144","author":"Renner","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib72","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1081-1206(10)63204-8","article-title":"Cyclosporin A in hyperimmunoglobulin E\u00a0syndrome","volume":"78","author":"Etzioni","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib73","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(96)91603-7","article-title":"Cyclosporin treatment of hyperimmunoglobulin E\u00a0syndrome","volume":"347","author":"Wolach","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.yadr.2007.08.001_bib74","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0091-6749(95)70185-0","article-title":"High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome","volume":"95","author":"Kimata","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib75","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1073\/pnas.86.24.10085","article-title":"Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma","volume":"86","author":"King","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.yadr.2007.08.001_bib76","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.bmt.1702446","article-title":"Bone marrow transplantation does not correct the hyper IgE syndrome","volume":"25","author":"Gennery","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.yadr.2007.08.001_bib77","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jaci.2004.02.001","article-title":"Phagocyte immunodeficiencies and their infections","volume":"113","author":"Rosenzweig","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib78","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/07853899909115974","article-title":"Mechanisms and consequences of phagocyte adhesion to endothelium","volume":"31","author":"Repo","year":"1999","journal-title":"Ann Med"},{"key":"10.1016\/j.yadr.2007.08.001_bib79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ng0501-69","article-title":"The gene defective in leukocyte adhesion deficiency II\u00a0encodes a putative GDP-fucose transporter","volume":"28","author":"Luhn","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.yadr.2007.08.001_bib80","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00130832-200412000-00003","article-title":"Leukocyte adhesion deficiency III: a group of integrin activation defects in hematopoietic lineage cells","volume":"4","author":"Etzioni","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib81","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1073\/pnas.080074897","article-title":"Human neutrophil immunodeficiency syndrome is\u00a0associated with an inhibitory Rac2 mutation","volume":"97","author":"Ambruso","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.yadr.2007.08.001_bib82","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/infdis\/152.4.668","article-title":"The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features","volume":"152","author":"Anderson","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.yadr.2007.08.001_bib83","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.it.2003.08.001","article-title":"LAD-III, a novel group of leukocyte integrin activation deficiencies","volume":"24","author":"Alon","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib84","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s004310051292","article-title":"Ulcero-necrotic cutaneous lesions in an infant","volume":"159","author":"Narchi","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yadr.2007.08.001_bib85","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nrmicro1004","article-title":"Antimicrobial reactive oxygen and nitrogen species: concepts and controversies","volume":"2","author":"Fang","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.yadr.2007.08.001_bib86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/416291a","article-title":"Killing activity of neutrophils is mediated through activation of proteases by K+ flux","volume":"416","author":"Reeves","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.yadr.2007.08.001_bib87","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0090-1229(86)90068-1","article-title":"Phagocyte defects","volume":"40","author":"White","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.yadr.2007.08.001_bib88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yadr.2007.08.001_bib89","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1067\/mai.2003.58","article-title":"Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay","volume":"111","author":"Jirapongsananuruk","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.yadr.2007.08.001_bib90","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yadr.2007.08.001_bib91","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The international chronic granulomatous disease cooperative study group","volume":"324","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yadr.2007.08.001_bib92","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ng1196-307","article-title":"Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome","volume":"14","author":"Nagle","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.yadr.2007.08.001_bib93","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.1095291","article-title":"Linking albinism and immunity: the secrets of secretory lysosomes","volume":"305","author":"Stinchcombe","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.yadr.2007.08.001_bib94","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1016\/S0190-9622(03)00123-3","article-title":"Hyperpigmentation in Chediak-Higashi syndrome","volume":"49","author":"Al-Khenaizan","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.yadr.2007.08.001_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(98)00020-4","article-title":"Myosin V in the brain: mutations lead to neurological defects","volume":"28","author":"Langford","year":"1998","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.yadr.2007.08.001_bib96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/76024","article-title":"Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome","volume":"25","author":"Menasche","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.yadr.2007.08.001_bib97","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1172\/JCI200318264","article-title":"Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1)","volume":"112","author":"Menasche","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yadr.2007.08.001_bib98","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0190-9622(98)70568-7","article-title":"Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature","volume":"38","author":"Mancini","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.yadr.2007.08.001_bib99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/pd.1970130104","article-title":"Prenatal diagnosis of syndromes associating albinism and immune deficiencies (Chediak-Higashi syndrome and variant)","volume":"13","author":"Durandy","year":"1993","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.yadr.2007.08.001_bib100","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00043426-200110000-00015","article-title":"Griscelli syndrome: rare neonatal syndrome of\u00a0recurrent hemophagocytosis","volume":"23","author":"Kumar","year":"2001","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Advances in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088208800700017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088208800700017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T17:21:59Z","timestamp":1546449719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088208800700017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":100,"alternative-id":["S088208800700017X"],"URL":"https:\/\/doi.org\/10.1016\/j.yadr.2007.08.001","relation":{},"ISSN":["0882-0880"],"issn-type":[{"value":"0882-0880","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}